Aide-mémoire for National Health Programmes: the clinical use of blood

Overview

Blood transfusion is an essential part of patient care. When used correctly, it saves lives and improves health. However, blood transfusion carries a potential risk of acute or delayed complications and transfusion-transmitted infections and should be prescribed only to treat conditions associated with significant morbidity or mortality that cannot be prevented or managed effectively by other means. Blood is a scarce human resource and ensuring its safety and clinical effectiveness requires investment – both human and financial. The national blood transfusion service (BTS) is responsible for ensuring the provision of an adequate supply of safe blood for all patients requiring transfusion. The national health programme should develop policies and strategies to reduce the need for transfusion, minimize
unnecessary transfusions and ensure the safe and appropriate use of blood and blood products.